Material Event Form 8 K

On September 30, 2024, Acadia Realty Trust (the "Company") and its operating partnership, Acadia Realty Limited Partnership (the "Operating Partnership"), entered into an underwriting agreement (the "Underwriting Agreement") with Wells Fargo Securities, LLC, Goldman Sachs & Co. LLC and Jefferies LLC, in their capacity as underwriters (the "Underwriters"), Wells Fargo Securities, LLC, Goldman Sachs & Co. LLC and Jefferies LLC, in their capacity as forward sellers (the "Forward Sellers"), and Wells Fargo Bank, National Association, Goldman Sachs & Co. LLC and Jefferies LLC, in their capacity as forward purchasers (the "Forward Purchasers"), relating to the offer and sale (the "Offering") of an aggregate of up to 5,000,000 common shares of beneficial interest, par value $0.001 per share ("Common Shares"), of the Company by the Forward Sellers in connection with the forward sale agreements described below. The Company granted the Underwriters an option to purchase up to an additional 750,000 Common Shares. The Company will not initially receive any proceeds from the sale of the Common Shares by the Forward Sellers.

The Common Shares were offered by the Underwriters to purchasers directly or through agents, or through brokers in brokerage transactions on the New York Stock Exchange, or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices.

In connection with the Offering, on September 30, 2024, the Company also entered into separate forward sale agreements ("Forward Sale Agreements") with each of the Forward Purchasers. In connection with the execution of the Forward Sale Agreements and at the Company's request, the Forward Sellers borrowed from third parties and sold to the Underwriters an aggregate of 5,000,000 Common Shares (subject to increase if the Underwriters exercise their option to purchase additional shares). The Company expects to physically settle the Forward Sale Agreements and receive proceeds, subject to certain adjustments, from the sale of those Common Shares upon one or more such physical settlements no later than September 30, 2025. Although the Company expects to settle the Forward Sale Agreements entirely by the physical delivery of Common Shares for cash proceeds, the Company may also elect to cash settle or net share settle all or a portion of its obligations under the Forward Sale Agreements, in which case, the Company may not receive any proceeds, and the Company may owe cash or Common Shares to the Forward Purchasers.

Assuming full physical settlement of the Forward Sale Agreements at an initial forward sale price of $22.89 per share (which is the price at which the Underwriters agreed to buy the Common Shares), the Company expects to receive net proceeds of approximately $114.0 million (or approximately $131.2 million if the Underwriters exercise their option to purchase additional Common Shares in full), after deducting underwriting discounts and fees and estimated expenses related to the Forward Sale Agreements and the Offering, upon settlement of the Forward Sale Agreements. The initial forward sale price is subject to certain adjustments pursuant to the terms of each of the Forward Sale Agreements. The Forward Sale Agreements are subject to early termination or settlement under certain circumstances.

The Company will contribute the net proceeds it receives upon the settlement of the Forward Sale Agreements to the Operating Partnership, which intends to use the net proceeds for general corporate purposes, including funding certain potential investment transactions described in the prospectus supplement for the Offering, working capital and the repayment of indebtedness. Pending such usage, the Operating Partnership expects to invest the net proceeds in short-term instruments.

The Common Shares were offered and sold pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-275356), which became effective upon filing with the Securities and Exchange Commission on November 7, 2023, and a prospectus supplement dated September 30, 2024.

The closing of the Offering occurred on October 2, 2024. The foregoing description of the Underwriting Agreement and the Forward Sale Agreements does not purport to be complete and is qualified in its entirety by reference to the exhibits filed with this Current Report on Form 8-K. In connection with the filing of the prospectus supplement, the Company is also filing the opinion of its counsel, Venable LLP, as Exhibit 5.1 to this Current Report on Form 8-K.